MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 219 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,000 | -99.1% | 36 | -99.4% | 0.00% | -100.0% |
| Q2 2020 | $215,000 | +6.4% | 6,525 | -12.5% | 0.01% | -12.5% |
| Q1 2020 | $202,000 | +320.8% | 7,459 | +208.1% | 0.02% | +433.3% |
| Q4 2019 | $48,000 | +585.7% | 2,421 | +362.0% | 0.00% | – |
| Q3 2019 | $7,000 | -84.1% | 524 | -86.8% | 0.00% | -100.0% |
| Q4 2018 | $44,000 | -63.0% | 3,974 | -11.9% | 0.00% | -55.6% |
| Q3 2018 | $119,000 | -99.9% | 4,509 | -40.7% | 0.01% | -30.8% |
| Q2 2018 | $155,522,000 | +1295916.7% | 7,605 | +1055.8% | 0.01% | +1200.0% |
| Q1 2018 | $12,000 | +20.0% | 658 | -5.6% | 0.00% | 0.0% |
| Q4 2017 | $10,000 | 0.0% | 697 | +21.4% | 0.00% | 0.0% |
| Q3 2017 | $10,000 | 0.0% | 574 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $10,000 | +233.3% | 574 | +157.4% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 223 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | – | 223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
| Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
| Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
| Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
| Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
| Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
| Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
| Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
| Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
| Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |